...

Cognition

Strategic Engagement with Pharma Decision-Makers:
A Tailored Approach

How It Works

Enabling Strategic Decisions in Pharma

Engagement with Pharma Leaders

Cognition provides detailed maps pinpointing the key decision-makers in drug discovery and preclinical trials, enabling direct and strategic engagement.

Tailored Solution Demonstrations

We offer dynamic visualizations that highlight decision-makers across therapeutic areas, ensuring AI Pharma solutions are demonstrated to the right stakeholders.

Market Strategy Enablement

Deep-dive profiles and actionable intelligence from Cognition empower AI Pharma companies to synchronize their AI solutions with pharma companies’ therapeutic area goals, accelerating market entry.
Lead Generation – Pharma
Why Our Clients Work with Us

Delivering Targeted Benefits Through Strategic Intelligence

  • Precision Engagement: Our intelligence leads to direct engagement with pivotal players in key therapeutic areas, significantly cutting down the time from discovery to lead generation.
  • Strategic Relationships: We help build and solidify relationships with Therapeutic Area Heads and R&D Leaders, leveraging insights to meet the unique challenges of drug discovery and development.
  • Focused Impact & ROI Maximization: By identifying critical roles through operational site analysis, we enhance engagement efficiency and prioritize high-impact areas for investment.
  • Adaptive Messaging: Customized communication strategies based on in-depth intelligence ensure that our clients’ marketing efforts are as effective and targeted as possible

CLIENT TESTIMONIALS

Results from Cognition's Strategic Intelligence

Our clients speak to the transformative impact of Cognition’s solutions:

Take the 'Pharma Lead Generation Maturity Assessment 2024' to measure your organization’s readiness compared to your peers/competitors and market benchmarks.

According to our 2023 Lead Generation Maturity Assessment, 71% of businesses find it difficult to identify and connect with key stakeholders in therapeutic areas due to the complex structures within pharmaceutical firms – with their existing lead generation tools. Additionally, 69% experienced delays in market entry and a decline in ROI because their solutions weren’t precisely aligned with the specific needs of their pharma clients, revealing significant gaps in their lead generation strategies.
Cognition
Scroll to Top